Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research

被引:121
作者
Cormier, Beatrice [1 ]
Rozenholc, Alexandre T. [1 ]
Gotlie, Walter [2 ]
Plante, Marie [3 ]
Giede, Christopher [4 ]
机构
[1] Ctr Hosp Univ Montreal, Dept Obstet & Gynecol, Gynecol Oncol Serv, Montreal, PQ H2L 4M1, Canada
[2] McGill Univ, Jewish Gen Hosp, Div Gynecol Oncol, Montreal, PQ H3T 1E2, Canada
[3] Univ Laval, Div Gynecol Oncol, Hotel Dieu Quebec, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada
[4] Univ Saskatoon, Dept Obstet Gynecol & Reprod Sci, Saskatoon, SK, Canada
关键词
Sentinel lymph node; Endometrial cancer; SURGICAL-MANAGEMENT; DIAGNOSTIC-ACCURACY; CERVICAL INJECTION; INDOCYANINE GREEN; MAPPING ALGORITHM; BLUE-DYE; STAGE-I; BIOPSY; RISK; METASTASIS;
D O I
10.1016/j.ygyno.2015.05.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Sentinel lymph node (SLN) procedure could be an attractive solution to the debate on lymphadenectomy in endometrial cancer; however challenges to interpreting the literature include marked heterogeneity across studies, a wide variety of injection techniques and a lack of uniformly accepted definitions for important outcomes. We aim to critically appraise the published literature and streamline terminology and methodology for future studies in this field. Methods. We conducted a PubMed search and included all original research of endometrial cancer patients having undergone SLN procedure with an n > 30. Data collected included injection technique, unilateral, bilateral, and para-aortic detection rates, and ultrastaging results. When different definitions were used for reporting outcomes, we recalculated the original study results according to our proposed definitions. Data was analyzed using descriptive statistics. Results. Seventeen studies met our inclusion criteria. Injection sites were categorized into cervical versus corporeal. Overall detection rates ranged from 60 to 100%; studies with n > 100 all had overall detection rates of >80%. Bilateral detection rates were higher with a combination of two injection agents. Para-aortic mapping was most frequent after corporeal injection techniques (39%), and was higher after deep vs. standard cervical injection (17% vs. 2%). The proportion of metastatic lymph nodes diagnosed through ultrastaging was high (around 40%) and ultrastaging of SLN upstaged approximately 5% of patients. Retrospectively applying a surgical algorithm revealed a sensitivity of 95%, a negative predictive value of 99%, and a false negative rate of 5% (with only 9 false negative cases remaining in total). Conclusion. Results of SLN research for endometrial cancer are promising. We believe that in future studies, uniform reporting is needed to improve our understanding of the safety and feasibility of SLN in EC. We propose 2 strategies: a checklist of elements to include in future reports and the standardization of key definitions. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:478 / 485
页数:8
相关论文
共 60 条
[1]   The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes [J].
Abu-Rustum, Nadeem R. ;
Gomez, Jacob D. ;
Alektiar, Kaled M. ;
Soslow, Robert A. ;
Hensley, Martee L. ;
Leitao, Mario M., Jr. ;
Gardner, Ginger J. ;
Sonoda, Yukio ;
Chi, Dennis S. ;
Barakat, Richard R. .
GYNECOLOGIC ONCOLOGY, 2009, 115 (02) :236-238
[2]   Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma? [J].
Abu-Rustum, Nadeem R. ;
Khoury-Collado, Fady ;
Pandit-Taskar, Neeta ;
Soslow, Robert A. ;
Dao, Fanny ;
Sonoda, Yukio ;
Levine, Douglas A. ;
Brown, Carol L. ;
Chi, Dennis S. ;
Barakat, Richard R. ;
Gemignani, Mary L. .
GYNECOLOGIC ONCOLOGY, 2009, 113 (02) :163-169
[3]   Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy [J].
Altgassen, Christopher ;
Mueller, Nadine ;
Hornemann, Amadeus ;
Kavallaris, Andreas ;
Hornung, Daniela ;
Diedrich, Klaus ;
Jarutat, Tiantom .
GYNECOLOGIC ONCOLOGY, 2009, 114 (02) :284-287
[4]  
[Anonymous], NCCN CLIN PRACT GUID
[5]  
[Anonymous], CAN CANC STAT
[6]  
[Anonymous], 1923, REV CHIR
[7]  
[Anonymous], 2014, GYNECOL ONCOL
[8]   Current issues in the management of endometrial cancer [J].
Bakkum-Gamez, Jamie N. ;
Gonzalez-Bosquet, Jesus ;
Laack, Nadia N. ;
Mariani, Andrea ;
Dowdy, Sean C. .
MAYO CLINIC PROCEEDINGS, 2008, 83 (01) :97-112
[9]   Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) [J].
Ballester, Marcos ;
Dubernard, Gil ;
Lecuru, Fabrice ;
Heitz, Denis ;
Mathevet, Patrice ;
Marret, Henri ;
Querleu, Denis ;
Golfier, Francois ;
Leblanc, Eric ;
Rouzier, Roman ;
Darai, Emile .
LANCET ONCOLOGY, 2011, 12 (05) :469-476
[10]   Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer [J].
Ballester, Marcos ;
Rouzier, Roman ;
Coutant, Charles ;
Kerrou, Khaldoun ;
Darai, Emile .
GYNECOLOGIC ONCOLOGY, 2009, 112 (02) :348-352